TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/8/25 20:00 | 1/7/25 | JANX | Janux Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Campbell David Alan | CA | DO | P,CEO | S | -300 | 60.00 | 0 | -5 | -2 | 293 | D | ||||||||||||||
12/27/24 20:00 | 12/24/24 | JANX | Janux Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Campbell David Alan | CA | DO | P,CEO | S | -1,405 | 56.19 | 0 | -25 | -10 | 217 | D | ||||||||||||||
12/3/24 20:00 | 12/3/24 | JANX | Janux Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Campbell David Alan | CA | DO | P,CEO | S | -1,005 | 67.00 | 0 | -15 | -6 | 242 | D | ||||||||||||||
11/27/24 20:00 | 11/25/24 | JANX | Janux Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Campbell David Alan | CA | DO | P,CEO | S | -1,290 | 51.60 | 0 | -25 | -9 | 257 | D | ||||||||||||||
10/30/24 19:30 | 10/28/24 | JANX | Janux Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Campbell David Alan | CA | DO | P,CEO | S | -1,339 | 53.54 | 0 | -25 | -8 | 282 | D | ||||||||||||||
9/27/24 19:30 | 9/27/24 | JANX | Janux Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Campbell David Alan | CA | DO | P,CEO | S | -1,158 | 46.31 | 0 | -25 | -8 | 307 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |